IP Library › Granted Patent US 7,320,792
Granted Patent B2
US 7,320,792 · App. 10/399,979 · Granted Jan 22, 2008

Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist

Assignee: Chugai Seiyaku Kabushiki Kaisha
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,320,792
App. No.
10/399,979
Granted
Jan 22, 2008
Kind
B2
Abstract

A preventive and therapeutic agent for psoriasis comprising an interleukin-6 (IL-6) antagonist such as, for example, an antibody against IL-6 receptor.

Claims (3)

1. A method of treating psoriasis comprising administering an effective amount of an antibody against interleukin-6 (IL-6) receptor to a subject in need thereof, wherein said antibody is monoclonal antibody PM-1 against human IL-6 receptor.

2. A method of treating psoriasis comprising administering an effective amount of an antibody against interleukin-6 (IL-6) receptor to a subject in need thereof, wherein said antibody is monoclonal antibody MR16-1 against mouse IL-6 receptor.

3. A method of treating psoriasis comprising administering an effective amount of an antibody against interleukin-6 (IL-6) receptor to a subject in need thereof, wherein said antibody is a humanized PM-1 antibody.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2003
From: ITO, HIROAKI; YOSHIZAKI, KAZUYUKI; NISHIMOTO, NORIHIRO; KISHIMOTO, TADAMITSU; SHIMAOKA, SHIN; KITAMURA, HIDETOMO; SUGIMOTO, MASAMICHI; AKAMATSU, KENICHI
To: CHUGAI SEIYAKU KABUSHIKI KAISHA
Reel/Frame 014514/0496 →
Priority Claims (1)
JP 2000-325904 · Oct 25, 2000 · national
Continuity (1)
Related Publication 20040028681A1 · Feb 12, 2004